[ Price : $8.95]
CBER posts Instructions for Using the Electronic Human Cell and Tissue Establishment Registration System (eHCTERS).[ Price : $8.95]
Federal Register notice: FDA posts a list of eight information collections that have been approved by OMB.[ Price : $8.95]
CDER says reorganization of the Office of New Drugs moved into Phase 2 11/4.[ Price : $8.95]
FDA releases an FDA-483 with seven observations issued following an inspection at Innoveix Pharmaceuticals.[ Price : $8.95]
Biopharma Reporter says that Pfizer CEO Albert Bourta is leading the effort to reform drug company rebates to payers that he says ...[ Price : $8.95]
Four stakeholders praise and recommend changes to an FDA draft guidance on general clinical pharmacology considerations for neonat...[ Price : $8.95]
CDER has completed reorganization of the Office of Hematology and Oncology Products into the Office of Oncologic Diseases.[ Price : $8.95]
FDA posts for comment a draft document with best practices for agency staff in conducting postmarket safety surveillance of drugs ...